PageOverview.com
 

Domains targeting keyword dvt/pe

Keyword dvt/pe was used in the provided list of websites.

 
Number of websites/domains displayed: 7
Results found: 7
 

Similar searches:

 

Websites discovered:

Blood clots, DVT, Coumadin, warfarin, & anticoagulation topics on ClotCare
http://pageoverview.com/website-report/clotcare.com
Blood clots, deep vein thrombosis (DVT), pulmonary embolism (PE) Coumadin / warfarin, PT - INR test, stroke, heart attack, thromboembolism, VTE, and other anticoagulation / antithrombotic therapy topics are explained on ClotCare by anticoagulation experts.
  • Expected expiration: March 29th in 2018
  • Creation date: March 29th in 2000
  • Renew date: March 30th in 2017
  • Google Analytics: 4029471-1
XARELTO® (rivaroxaban) Information for Healthcare Professionals | XARELTO® (rivaroxaban) HCP
http://pageoverview.com/website-report/xareltohcp.com
Discover XARELTO®, a Factor Xa inhibitor indicated to reduce stroke risk in patients with nonvalvular AF, to treat DVT & PE and for extended risk reduction, and for DVT prophylaxis after knee or hip replacement surgery.
  • Expected expiration: September 5th in 2018
  • Creation date: September 5th in 2008
  • Renew date: September 1st in 2016
  • Google Analytics: 6230610-8
Dr. Sudi « Dr. Deepak Sudheendra « Interventional Radiologist
http://pageoverview.com/website-report/drsudi.com
This website is an educational resource for the minimally invasive treatment of cancer and venous disease including dvt, varicose veins, and PE.
  • Expected expiration: December 12th in 2020
  • Creation date: December 12th in 2015
  • Renew date: December 12th in 2015
  • Google Plus Account: 116959900571569439638
Xarelto® - (rivaroxaban) - The Most Broadly Indicated NOAC
http://pageoverview.com/website-report/xarelto.com
Information about Xarelto (Rivaroxaban), stroke prevention in atrial fibrillation, treatment and prevention of VTE (DVT/PE) and Secondary Prevention after ACS
  • Expected expiration: January 16th in 2019
  • Creation date: January 16th in 2002
  • Renew date: January 12th in 2017
LOVENOX®-: Treatment for Deep Vein Thrombosis (DVT) Blood Clots
http://pageoverview.com/website-report/lovenox.com
LOVENOX® is an anticoagulant therapy indicated to help reduce the risk of developing DVT, or deep vein thrombosis, which may lead to pulmonary embolism (PE)
  • Expected expiration: January 22nd in 2019
  • Creation date: January 22nd in 2000
  • Renew date: January 4th in 2017
Airhealth.org - Home - Avoid Economy Class Syndrome
http://pageoverview.com/website-report/airhealth.org
Avoid Economy Class Syndrome, blood clots formed during air travel. Information for passengers, pilots, and healthcare workers.
  • Expected expiration: January 11th in 2019
  • Creation date: January 11th in 2001
  • Renew date: November 21st in 2017
Medworx | Enhancing Patient Outcomes | 601.665.4094 - Home
http://pageoverview.com/website-report/medworx.us
Medworx is a licensed, Medicare-approved, Durable Medical Equipment (DME) company offering products and services to surgical healthcare providers to increase patient safety, enhance patient outcomes, reduce risk, and improve operational and financial performance. With years of experience working with physicians and patients, Medworx offers flexible programs to meet your needs including DVT/PE Prevention Program and Orthopedic Bracing Solutions.
  • Expected expiration: June 24th in 2020
  • Creation date: June 24th in 2010
  • Renew date: May 5th in 2015
0.0107 // 2024-05-25 07:46:04
All Rights reserved 2018 © PageOverview.com